MedPath

Betaine

Generic Name
Betaine
Brand Names
Amversio, Cystadane, EnBrace HR, EnLyte
Drug Type
Small Molecule
Chemical Formula
C5H11NO2
CAS Number
107-43-7
Unique Ingredient Identifier
3SCV180C9W
Background

Betaine is a methyl group donor that functions in the normal metabolic cycle of methionine. It is a naturally occurring choline derivative commonly ingested through diet, with a role in regulating cellular hydration and maintaining cell function. Homocystinuria is an inherited disorder that leads to the accumulation of homocysteine in plasma and urine. Currently, no treatments are available to correct the genetic causes of homocystinuria. However, in order to normalize homocysteine levels, patients can be treated with vitamin B6 (pyridoxine), vitamin B12 (cobalamin), folate and specific diets. Betaine reduces plasma homocysteine levels in patients with homocystinuria. Although it is present in many food products, the levels found there are insufficient to treat this condition. The FDA and EMA have approved the product Cystadane (betaine anhydrous, oral solution) for the treatment of homocystinuria, and the EMA has approved the use of Amversio (betaine anhydrous, oral powder).

Indication

Betaine is indicated for the treatment of homocystinuria in pediatric and adult patients to decrease elevated homocysteine blood levels. Included within the category of homocystinuria are deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl).

Associated Conditions
Homocystinuria, Homocystinuria Due to Cystathionine Beta-Synthase Deficiency, Homocystinuria due to MTHFR deficiency, Homocystinuria due to cobalamin cofactor metabolism (cbl) defect

The Therapeutic Effect of Betaine in Syringomyelia

Phase 2
Recruiting
Conditions
Syringomyelia
Interventions
Drug: Placebo
First Posted Date
2024-03-13
Last Posted Date
2024-03-13
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
30
Registration Number
NCT06308367
Locations
🇨🇳

Fengzeng Jian, Beijing, Beijing, China

Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction

Phase 3
Completed
Conditions
Xerostomia
Interventions
Drug: Xylitol, Lactoperoxidase, Lysozyme, Lactoferrin
First Posted Date
2022-04-22
Last Posted Date
2022-04-22
Lead Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Target Recruit Count
40
Registration Number
NCT05342272
Locations
🇮🇹

ASST Spedali Civili di Brescia, Brescia, Italy

Betaine METABOLISM OF PATIENTS With Homocystinuria

Phase 2
Completed
Conditions
Homocystinuria
Interventions
First Posted Date
2015-03-31
Last Posted Date
2023-02-03
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
12
Registration Number
NCT02404337
Locations
🇫🇷

Assistance Publique - Hôpitaux de Paris, Paris, France

Choline Dehydrogenase and Sperm Function: Effects of Betaine

Phase 1
Completed
Conditions
Men Carrying 2 Minor Alleles for Choline Dehydrogenase rs12676
Male Infertility
Interventions
First Posted Date
2014-04-24
Last Posted Date
2016-09-08
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
6
Registration Number
NCT02122211
Locations
🇺🇸

UNC Nutrition Research Institute, Kannapolis, North Carolina, United States

Metabolic Effects of Betaine Supplementation

Phase 2
Completed
Conditions
Dysglycemia
Obesity
Interventions
Drug: Placebo
First Posted Date
2013-09-25
Last Posted Date
2021-04-20
Lead Sponsor
Joslin Diabetes Center
Target Recruit Count
28
Registration Number
NCT01950039
Locations
🇺🇸

Joslin Diabetes Center and Brigham and Womens Hospital, Boston, Massachusetts, United States

Betaine and Peroxisome Biogenesis Disorders

Phase 3
Completed
Conditions
Peroxisome Biogenesis Disorders
Interventions
First Posted Date
2013-04-24
Last Posted Date
2016-06-28
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Target Recruit Count
12
Registration Number
NCT01838941
Locations
🇨🇦

Montreal Children's Hospital, Montreal, Quebec, Canada

A Preliminary Study of Choline and Betaine Supplementation Among Adults Exposed to Arsenic in Bangladesh

Phase 4
Completed
Conditions
Arsenic Metabolites Measured in Urine
Interventions
First Posted Date
2012-12-17
Last Posted Date
2014-08-28
Lead Sponsor
Columbia University
Target Recruit Count
60
Registration Number
NCT01749982
Locations
🇧🇩

Columbia University Arsenic Research Project, Dhaka, Bangladesh

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Early Phase 1
Terminated
Conditions
Chronic Hepatitis C
Genotype 1
Relapse
Interventions
Drug: Peginterferon alpha 2a
First Posted Date
2009-04-16
Last Posted Date
2023-11-30
Lead Sponsor
University of Nebraska
Target Recruit Count
2
Registration Number
NCT00882193
Locations
🇺🇸

University of Nebraska Medical Center, Omaha, Nebraska, United States

Betaine in Patients With Nonalcoholic Steatohepatitis

Phase 2
Completed
Conditions
Nonalcoholic Steatohepatitis
Interventions
Drug: Identical Placebo
First Posted Date
2008-01-07
Last Posted Date
2015-04-08
Lead Sponsor
Mayo Clinic
Target Recruit Count
26
Registration Number
NCT00586911
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

🇺🇸

University of Florida at Gainesville, Gainesville, Florida, United States

Dietary Supplements for the Treatment of Angelman Syndrome

Not Applicable
Completed
Conditions
Angelman Syndrome
Nervous System Diseases
Interventions
First Posted Date
2006-07-06
Last Posted Date
2012-09-24
Lead Sponsor
University of California, San Diego
Target Recruit Count
90
Registration Number
NCT00348933
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

🇺🇸

Rady Children's Hospital San Diego, San Diego, California, United States

🇺🇸

Children's Hospital Boston, Boston, Massachusetts, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath